Vall d’Hebron Hospital receives three Best in Class awards

The Best in Class awards are an initiative by the Gaceta Médica journal, published by the publishing house Contenidos e Información de Salud, and the Chair for Medical Innovation and Management of the Universidad Rey Juan Carlos. The award aims to acknowledge publically the best primary healthcare centre, the best hospital and the best services or units in Spain, whether they be state funded or private centres, which stand out for the service they offer to their patients.
 
The awards are offered to candidates depending on the average points obtained in the Index of Quality in Healthcare (ICAP), created especially for these awards, and which are established according to the multivariable analysis of data collected from specific questionnaires filled out by hospitals and primary healthcare centres online.
 
Joan X. Comella, in name of the Vall d'Hebron Research Institute (VHIR), Josep Sánchez de Toledo, for the Haematopoiesis Transplant Programme; and Jaume Sastre in name of Xavier Montalbán, for the project Multiple Sclerosis Centre (Cemcat), were present at the ceremony to receive the award.
 
The Vall d’Hebron Research Institute, a UAB-affiliated centre, won the award to the best centre in the sector of research and innovation. This double concept adapts perfectly to the centre's philosophy, in which it defines its missions as a state-funded institute promoting and developing biomedical research and innovation.
 
Cemcat is a centre dedicated to the integrated service of multiple sclerosis patients (early diagnosis, pharmacological, symptomatic and rehabilitation treatments), and includes intense scientific and teaching activities. It is a leading centre in Spain and every year it organises an online master's degree in neuroimmunology, in collaboration with the Universitat Autònoma de Barcelona.
 
With a yearly average of 40 transplants, the Haematopoiesis Transplant Unit is the most active in Spain and, up until now, it has treated over 1,100 children with different types of blood diseases, immunodeficiency, metabolic disorders and tumours. For the second consecutive year, the Paediatric Onco-haematology Service, a nationally and internationally renowned centre in the treatment of cancers in children and blood diseases, has received this award.